Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,780 | 353,069 | 164,894 | 214,877 | 100,461 |
| Marketable Securities | 376,622 | 232,045 | 285,605 | 255,102 | 283,328 |
| Receivables | 133,303 | 160,261 | 138,912 | 120,822 | 148,576 |
| Other current assets | 26,480 | 19,958 | 22,549 | 32,035 | 34,321 |
| TOTAL | $675,185 | $765,333 | $611,960 | $622,836 | $566,686 |
| Non-Current Assets | |||||
| PPE Net | 86,049 | 68,622 | 62,287 | 60,166 | 51,086 |
| Investments And Advances | 415,621 | 493,182 | 485,047 | 407,284 | 393,250 |
| Intangibles | 211,049 | 86,036 | 86,811 | 85,433 | 29,936 |
| Other Non-Current Assets | 73,758 | 52,417 | 32,615 | 28,949 | 8,897 |
| TOTAL | $786,477 | $700,257 | $666,760 | $581,832 | $483,169 |
| Total Assets | $1,461,662 | $1,465,590 | $1,278,720 | $1,204,668 | $1,049,855 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,999 | 14,999 | 15,137 | 15,107 | 15,077 |
| Accounts payable and accrued liabilities | 37,109 | 23,699 | 20,494 | 24,868 | 14,743 |
| Accrued Expenses | 27,100 | 11,847 | 17,689 | N/A | N/A |
| Other current liabilities | 39,722 | 32,920 | 45,056 | 89,308 | 65,305 |
| TOTAL | $127,527 | $141,714 | $105,310 | $147,158 | $121,524 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 5,947 | 5,899 |
| Other Non-Current Liabilities | 23,840 | 11,338 | 8,192 | 7,408 | 1,872 |
| TOTAL | $23,402 | $10,916 | $7,530 | $13,057 | $7,606 |
| Total Liabilities | $150,929 | $152,630 | $112,840 | $160,215 | $129,130 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,266 | 30,327 | 30,253 | 29,831 | 29,521 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 823,113 | 811,576 | 657,597 | 553,258 | 430,736 |
| Other shareholders' equity | -16,449 | -5,665 | 6,372 | 7,461 | 7,731 |
| TOTAL | $1,310,733 | $1,312,960 | $1,165,880 | $1,044,453 | $920,725 |
| Total Liabilities And Equity | $1,461,662 | $1,465,590 | $1,278,720 | $1,204,668 | $1,049,855 |